← Leaderboards
Daniel E Nixon
Virginia Commonwealth University
$2,851,547
Attributed
$2,851,547
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–06$2M$1.5M$1M$500K$0
'05
'06
Funding mix
By agency
NIH$2,851,547 · 4
By mechanism
U01$2,529,560 · 1
K08$249,426 · 1
M01$72,561 · 2
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Carlos R Escalante$4,815,516
- Michael A McVoy$9,920,342
- Karen S Ingersoll$10,539,581
- Deborah L Haller$2,805,351
- John D Roberts$6,720,279
Others in their field
Top investigators on “Virus Protein”
- David Heimbrook · Leidos Biomedical Research, Inc.$190,813,020
- Dennis R. Burton · Scripps Research Institute$85,045,833
- Gregory D Peterson · University Of Tennessee Knoxville$84,527,696
- Constance Ann Benson · University Of California, San Diego$65,790,143
- James E Crowe · Vanderbilt University Medical Center$60,519,858
- Rama Rao Amara · Emory University$57,729,594
Research focus
Virus ProteinAids /Hiv DiagnosisGene MutationGene TargetingGenetic Regulatory ElementGenomeHerpesviridaeIntracellular TransportLaboratory RabbitOligonucleotidesProtein PurificationProtein Structure FunctionRecombinant VirusTranscription FactorVirus AssemblyVirus GeneticsVirus Infection MechanismBaculoviridaeChemical CleavageCircular DnaDna Binding ProteinDrug Screening /EvaluationEndonucleaseGel Mobility Shift Assay
Grant awards (7)
RICHMOND AIDS CONSORTIUM 'CPCRA'$630,857
U01 · FY2006 · AI · contact PI
PHASE III STUDY OF SUBCUTANEOUS RECOMBINANT IL-2 IN PATIENTS W/ HIV-1 INFECTION$15,753
M01 · FY2006 · RR · contact PI
RICHMOND AIDS CONSORTIUM 'CPCRA'$949,819
U01 · FY2005 · AI
PHASE III STUDY OF SUBCUTANEOUS RECOMBINANT IL-2 IN PATIENTS W/ HIV-1 INFECTION$56,808
M01 · FY2005 · RR
RICHMOND AIDS CONSORTIUM 'CPCRA'$948,884
U01 · FY2004 · AI
HERPESVIRUS GENOMIC CLEAVAGE$124,713
K08 · FY2001 · AI
HERPESVIRUS GENOMIC CLEAVAGE$124,713
K08 · FY2000 · AI